NUCLEAR DIFFUSENESS AS A MEASURE OF TEXTURE - DEFINITION AND APPLICATION TO THE COMPUTER-ASSISTED DIAGNOSIS OF PARATHYROID ADENOMA AND CARCINOMA

被引:26
作者
EINSTEIN, AJ
BARBA, J
UNGER, PD
GIL, J
机构
[1] CUNY MT SINAI SCH MED, LILLIAN & HENRY M STRATTON HANS POPPER DEPT PATHO, NEW YORK, NY 10029 USA
[2] CUNY CITY COLL, DEPT ELECT ENGN, NEW YORK, NY 10031 USA
关键词
MORPHOMETRY; IMAGE ANALYSIS; NUCLEAR TEXTURE; NUCLEAR DIFFUSENESS; PARATHYROID CARCINOMA; PARATHYROID ADENOMA; ARTIFICIAL NEURAL NETWORKS;
D O I
10.1111/j.1365-2818.1994.tb03510.x
中图分类号
TH742 [显微镜];
学科分类号
摘要
A measure of texture, the nuclear diffuseness, was formulated for use in biological classification, and specifically to characterize quantitatively chromatin texture. Nuclear diffuseness corresponds to the amount of local intensity variation in the digitized image of a nuclear profile. As a setting in which to test the efficacy of nuclear diffuseness as a diagnostic tool, the identification of parathyroid adenoma and carcinoma was considered. Digitized images of sections of parathyroid chief cell nuclei were obtained from 16 biopsies, and the nuclear diffuseness, as well as other morphometric descriptors, were computed. With just the average nuclear diffuseness and average nuclear profile area, jackknife (leave-one-out) classification using an artificial neural network was able to diagnose correctly and unambiguously the condition (normal, parathyroid adenoma, or parathyroid carcinoma) in 15 of 16 cases. In one case, the neural network assigned a higher weight to the correct diagnosis, but was unable to distinguish between normal and adenoma conclusively.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 44 条
[1]  
BIBBO M, 1990, CANCER RES, V50, P147
[2]  
Blichert-Toft M, 1993, Ugeskr Laeger, V155, P765
[3]   HISTOPATHOLOGICAL VARIABLES AND DNA CYTOMETRY IN PARATHYROID CARCINOMA [J].
BONDESON, L ;
SANDELIN, K ;
GRIMELIUS, L .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1993, 17 (08) :820-829
[4]  
CHRISTENSSON T, 1976, ACTA MED SCAND, V200, P131
[5]  
DAWSON AE, 1991, AM J CLIN PATHOL, V95, pS29
[6]  
DeLellis RA, 1993, ATLAS TUMOR PATHOLOG
[7]  
DELIGDISCH L, 1993, CANCER, V72, P3253, DOI 10.1002/1097-0142(19931201)72:11<3253::AID-CNCR2820721120>3.0.CO
[8]  
2-1
[9]   MORPHOMETRIC DIFFERENTIATION BETWEEN RESPONSIVE TUMOR-CELLS AND MESOTHELIAL HYPERPLASIA IN 2ND-LOOK OPERATIONS FOR OVARIAN-CANCER [J].
DELIGDISCH, L ;
KERNER, H ;
COHEN, CJ ;
DARGENT, D ;
GIL, J .
HUMAN PATHOLOGY, 1993, 24 (02) :143-147
[10]   PROGNOSTIC-SIGNIFICANCE OF DNA CONTENT AND NUCLEAR MORPHOLOGY IN BORDERLINE OVARIAN-TUMORS [J].
DRESCHER, CW ;
FLINT, A ;
HOPKINS, MP ;
ROBERTS, JA .
GYNECOLOGIC ONCOLOGY, 1993, 48 (02) :242-246